Product Information

HYDROCODONE-CHLORPHEN ER SUSP is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.6205 per ML under NDC 27808008602. Its NADAC has been published 579 times since Oct 14, 2015.

FDA first approved this application on Oct 1, 2010.

HYDROCODONE-CHLORPHEN ER SUSP

Hydrocodone Polistirex and Chlorpheniramine Polistirex
$0.6205per ML
DEA Schedule CII

Strength

8; 10 mg/5mL; mg/5mL

NDC

27808008602

Classification

Generic

Dosage Form

SUSPENSION, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091632

FDA Approved

10/1/2010

On Market Since

3/6/2015

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-CHLORPHEN ER SUSP has been published 579 times since Oct 14, 2015, and over the history we have for it it has risen 35.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6205 per ML
All-time high$0.6812 (Jul 15, 2026)
All-time low$0.2804 (Nov 20, 2024)
52-week high$0.6812
52-week low$0.4025
Median price$0.3932
Average price$0.4069
Largest weekly change+39.0% (Jul 21, 2021)
Weeks tracked579
Tracking sinceOct 14, 2015

Price History

1W

0.0%

1M

-2.2%

3M

-8.3%

6M

-6.3%

1Y

+55.4%

3Y

+51.6%

5Y

+101.2%

All

+35.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 23%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-CHLORPHEN ER SUSP?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-CHLORPHEN ER SUSP, manufactured by Cranbury Pharmaceuticals, LLC, is $0.6205 per ML (NDC 27808008602), effective Nov 11, 2026.

How has the price of HYDROCODONE-CHLORPHEN ER SUSP changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-CHLORPHEN ER SUSP has risen 35.7%. It has been tracked across 579 weekly CMS publications since Oct 14, 2015.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-CHLORPHEN ER SUSP?

Since Oct 14, 2015, the NADAC for HYDROCODONE-CHLORPHEN ER SUSP has ranged from a low of $0.2804 (Nov 20, 2024) to a high of $0.6812 (Jul 15, 2026), with a median of $0.3932 per ML.

Are there cheaper alternatives to HYDROCODONE-CHLORPHEN ER SUSP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-CHLORPHEN ER SUSP, is $0.4756 per ML — about 23% below HYDROCODONE-CHLORPHEN ER SUSP.

Who manufactures HYDROCODONE-CHLORPHEN ER SUSP?

HYDROCODONE-CHLORPHEN ER SUSP (NDC 27808008602) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.